| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 7 | 2024 | 118 | 4.370 |
Why?
|
| Neural Tube Defects | 9 | 2022 | 359 | 2.620 |
Why?
|
| Hypothyroidism | 4 | 2024 | 207 | 2.460 |
Why?
|
| China | 16 | 2024 | 626 | 2.270 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2024 | 77 | 2.060 |
Why?
|
| Pregnancy | 36 | 2024 | 7819 | 2.040 |
Why?
|
| Pregnancy Complications | 4 | 2024 | 537 | 1.990 |
Why?
|
| Pregnancy Outcome | 7 | 2024 | 661 | 1.890 |
Why?
|
| Encephalitis Virus, Japanese | 3 | 2023 | 25 | 1.790 |
Why?
|
| Translocation, Genetic | 16 | 2015 | 1269 | 1.780 |
Why?
|
| Thyrotropin | 5 | 2024 | 116 | 1.630 |
Why?
|
| Thyroid Gland | 2 | 2024 | 358 | 1.580 |
Why?
|
| Thyroxine | 4 | 2024 | 115 | 1.560 |
Why?
|
| Encephalitis, Japanese | 2 | 2020 | 21 | 1.470 |
Why?
|
| Vaccines, DNA | 2 | 2020 | 114 | 1.380 |
Why?
|
| Pancreatitis | 2 | 2024 | 278 | 1.190 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2015 | 779 | 1.160 |
Why?
|
| Premature Birth | 4 | 2024 | 420 | 1.150 |
Why?
|
| Pregnancy Trimester, First | 6 | 2024 | 132 | 1.150 |
Why?
|
| Uric Acid | 2 | 2024 | 116 | 1.120 |
Why?
|
| Particulate Matter | 2 | 2024 | 94 | 1.100 |
Why?
|
| Female | 106 | 2024 | 147052 | 1.030 |
Why?
|
| Immunoglobulin Heavy Chains | 7 | 2015 | 247 | 0.990 |
Why?
|
| CD5 Antigens | 3 | 2015 | 122 | 0.980 |
Why?
|
| Air Pollutants | 2 | 2024 | 145 | 0.970 |
Why?
|
| Basophils | 1 | 2024 | 42 | 0.960 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2024 | 33 | 0.960 |
Why?
|
| Pyroptosis | 1 | 2024 | 28 | 0.940 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 89 | 0.930 |
Why?
|
| Pre-Eclampsia | 2 | 2024 | 214 | 0.910 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 66 | 0.910 |
Why?
|
| Flavivirus | 1 | 2023 | 23 | 0.890 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 944 | 0.880 |
Why?
|
| STAT5 Transcription Factor | 1 | 2024 | 223 | 0.870 |
Why?
|
| Adiponectin | 1 | 2023 | 167 | 0.860 |
Why?
|
| Lung Injury | 1 | 2024 | 136 | 0.840 |
Why?
|
| Autoimmunity | 1 | 2024 | 275 | 0.830 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 318 | 0.820 |
Why?
|
| Immunophenotyping | 19 | 2015 | 1700 | 0.820 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 306 | 0.810 |
Why?
|
| Eosinophilia | 1 | 2024 | 189 | 0.810 |
Why?
|
| Creatinine | 1 | 2024 | 550 | 0.810 |
Why?
|
| Dengue | 1 | 2023 | 116 | 0.810 |
Why?
|
| Uranium | 1 | 2021 | 7 | 0.810 |
Why?
|
| Myeloproliferative Disorders | 5 | 2024 | 801 | 0.800 |
Why?
|
| Air Pollution | 1 | 2023 | 96 | 0.800 |
Why?
|
| Gene Rearrangement | 5 | 2016 | 797 | 0.800 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 3 | 2011 | 38 | 0.800 |
Why?
|
| Mutation | 18 | 2024 | 15579 | 0.800 |
Why?
|
| Humans | 126 | 2024 | 270414 | 0.790 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 258 | 0.780 |
Why?
|
| B-Lymphocytes | 7 | 2012 | 1347 | 0.770 |
Why?
|
| Zika Virus | 1 | 2023 | 150 | 0.770 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 135 | 0.760 |
Why?
|
| Trace Elements | 2 | 2020 | 36 | 0.750 |
Why?
|
| Selenium | 2 | 2020 | 47 | 0.750 |
Why?
|
| Cholesterol | 1 | 2024 | 680 | 0.750 |
Why?
|
| Japanese Encephalitis Vaccines | 1 | 2020 | 13 | 0.750 |
Why?
|
| Lymphoma, Follicular | 4 | 2015 | 604 | 0.740 |
Why?
|
| Propensity Score | 1 | 2024 | 784 | 0.740 |
Why?
|
| Zika Virus Infection | 1 | 2023 | 174 | 0.740 |
Why?
|
| Listeriosis | 1 | 2020 | 36 | 0.730 |
Why?
|
| Prospective Studies | 11 | 2024 | 13269 | 0.730 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 3 | 2013 | 309 | 0.710 |
Why?
|
| Chromosomes, Human, Pair 14 | 6 | 2013 | 287 | 0.700 |
Why?
|
| Fever | 4 | 2014 | 510 | 0.690 |
Why?
|
| Myelodysplastic Syndromes | 11 | 2024 | 3063 | 0.660 |
Why?
|
| Leukemia, Myeloid, Acute | 15 | 2014 | 7062 | 0.660 |
Why?
|
| Trinucleotide Repeats | 1 | 2019 | 107 | 0.660 |
Why?
|
| Fetal Blood | 1 | 2022 | 479 | 0.660 |
Why?
|
| Adult | 54 | 2024 | 80583 | 0.650 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 212 | 0.650 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2019 | 126 | 0.630 |
Why?
|
| Ambulatory Care Facilities | 2 | 2011 | 302 | 0.620 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 3 | 2013 | 47 | 0.610 |
Why?
|
| Macrophages | 2 | 2024 | 1372 | 0.610 |
Why?
|
| Immunity | 1 | 2020 | 359 | 0.610 |
Why?
|
| Immunoglobulin Variable Region | 4 | 2013 | 173 | 0.610 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2015 | 1232 | 0.610 |
Why?
|
| Antibodies, Viral | 5 | 2020 | 1361 | 0.600 |
Why?
|
| Oligospermia | 1 | 2017 | 67 | 0.600 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 8 | 2012 | 2585 | 0.600 |
Why?
|
| In Situ Hybridization, Fluorescence | 15 | 2016 | 2258 | 0.600 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 2015 | 439 | 0.580 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2014 | 488 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2016 | 1515 | 0.570 |
Why?
|
| Reproduction | 1 | 2019 | 257 | 0.570 |
Why?
|
| Bone Marrow | 14 | 2015 | 2374 | 0.570 |
Why?
|
| Body Mass Index | 1 | 2024 | 2293 | 0.550 |
Why?
|
| Anxiety | 2 | 2023 | 1240 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 3 | 5 | 2012 | 319 | 0.530 |
Why?
|
| Chromosome Aberrations | 13 | 2019 | 1978 | 0.530 |
Why?
|
| Echinococcosis | 1 | 2015 | 15 | 0.530 |
Why?
|
| Clone Cells | 4 | 2010 | 553 | 0.530 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 442 | 0.520 |
Why?
|
| Nuclear Proteins | 6 | 2015 | 3384 | 0.520 |
Why?
|
| Myeloid Cells | 2 | 2014 | 276 | 0.520 |
Why?
|
| Spleen | 2 | 2017 | 692 | 0.510 |
Why?
|
| Cohort Studies | 10 | 2024 | 9477 | 0.510 |
Why?
|
| Case-Control Studies | 9 | 2023 | 6241 | 0.500 |
Why?
|
| Angiotensin I | 1 | 2015 | 18 | 0.500 |
Why?
|
| Pancreas, Exocrine | 1 | 2015 | 22 | 0.500 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 242 | 0.490 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2015 | 83 | 0.490 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 530 | 0.480 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2015 | 556 | 0.470 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 2 | 2013 | 188 | 0.470 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2011 | 40 | 0.470 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2013 | 5 | 0.470 |
Why?
|
| Bayes Theorem | 8 | 2022 | 1057 | 0.470 |
Why?
|
| Risk Factors | 10 | 2024 | 18231 | 0.460 |
Why?
|
| Carrier Proteins | 2 | 2015 | 2054 | 0.460 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2023 | 2547 | 0.460 |
Why?
|
| Karyotyping | 10 | 2019 | 1022 | 0.460 |
Why?
|
| Abdomen | 1 | 2015 | 337 | 0.450 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2015 | 368 | 0.450 |
Why?
|
| Depression | 2 | 2023 | 1766 | 0.450 |
Why?
|
| Primary Myelofibrosis | 3 | 2017 | 878 | 0.440 |
Why?
|
| Aged, 80 and over | 30 | 2024 | 30768 | 0.440 |
Why?
|
| Membrane Proteins | 1 | 2024 | 2914 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1427 | 0.440 |
Why?
|
| Fetus | 6 | 2022 | 616 | 0.440 |
Why?
|
| Immunoglobulin M | 3 | 2013 | 354 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2013 | 1787 | 0.430 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2012 | 11 | 0.430 |
Why?
|
| Young Adult | 21 | 2023 | 22096 | 0.430 |
Why?
|
| Maternal Exposure | 3 | 2024 | 159 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2013 | 175 | 0.420 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2013 | 819 | 0.420 |
Why?
|
| Primary Ovarian Insufficiency | 2 | 2024 | 64 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2012 | 105 | 0.420 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2023 | 163 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2015 | 651 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2014 | 228 | 0.420 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2022 | 2425 | 0.420 |
Why?
|
| Male | 61 | 2024 | 127408 | 0.410 |
Why?
|
| Middle Aged | 52 | 2024 | 89415 | 0.410 |
Why?
|
| Flow Cytometry | 11 | 2015 | 3071 | 0.410 |
Why?
|
| Aged | 44 | 2024 | 72802 | 0.400 |
Why?
|
| Infant, Newborn | 8 | 2024 | 8535 | 0.400 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 931 | 0.390 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 480 | 0.390 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 471 | 0.390 |
Why?
|
| Isochromosomes | 1 | 2011 | 55 | 0.390 |
Why?
|
| Chromosome Deletion | 3 | 2013 | 1018 | 0.390 |
Why?
|
| Nose Neoplasms | 2 | 2013 | 234 | 0.390 |
Why?
|
| Mercury | 2 | 2021 | 32 | 0.380 |
Why?
|
| Signal Transduction | 4 | 2024 | 12135 | 0.380 |
Why?
|
| DNA Mutational Analysis | 5 | 2012 | 2311 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2014 | 2395 | 0.370 |
Why?
|
| Immunohistochemistry | 15 | 2016 | 7702 | 0.370 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2010 | 11 | 0.360 |
Why?
|
| Strongylida Infections | 1 | 2010 | 17 | 0.360 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1772 | 0.360 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 500 | 0.360 |
Why?
|
| Fetal Growth Retardation | 2 | 2024 | 204 | 0.350 |
Why?
|
| Genes, p53 | 2 | 2011 | 1122 | 0.350 |
Why?
|
| Neoplasms, Second Primary | 5 | 2015 | 1377 | 0.350 |
Why?
|
| Biomarkers, Tumor | 9 | 2021 | 10623 | 0.350 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 3234 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2016 | 833 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 7 | 2020 | 2401 | 0.340 |
Why?
|
| Cleft Palate | 2 | 2022 | 137 | 0.340 |
Why?
|
| Cleft Lip | 2 | 2022 | 139 | 0.330 |
Why?
|
| Peptide Fragments | 1 | 2015 | 1294 | 0.330 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 2099 | 0.330 |
Why?
|
| Ovary | 3 | 2022 | 684 | 0.330 |
Why?
|
| Lymphoma, Mantle-Cell | 4 | 2013 | 736 | 0.330 |
Why?
|
| Animals | 22 | 2024 | 60939 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2015 | 3664 | 0.320 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 393 | 0.310 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 5 | 2015 | 1701 | 0.310 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 2 | 2022 | 70 | 0.310 |
Why?
|
| Adolescent | 18 | 2021 | 32251 | 0.300 |
Why?
|
| Lymphoma, B-Cell | 5 | 2016 | 917 | 0.300 |
Why?
|
| Communicable Diseases | 1 | 2010 | 209 | 0.300 |
Why?
|
| Communication | 2 | 2011 | 908 | 0.300 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 429 | 0.290 |
Why?
|
| Leukemia, Myeloid | 3 | 2007 | 964 | 0.290 |
Why?
|
| Apoptosis | 6 | 2022 | 7757 | 0.290 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2006 | 47 | 0.290 |
Why?
|
| Blood Pressure | 2 | 2023 | 1525 | 0.280 |
Why?
|
| DNA Virus Infections | 1 | 2006 | 28 | 0.280 |
Why?
|
| DNA Viruses | 1 | 2006 | 47 | 0.280 |
Why?
|
| Fusion Proteins, bcr-abl | 7 | 2014 | 1126 | 0.270 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2007 | 116 | 0.260 |
Why?
|
| Blast Crisis | 3 | 2012 | 581 | 0.260 |
Why?
|
| Herpesvirus 4, Human | 2 | 2013 | 954 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 8 | 4 | 2009 | 330 | 0.260 |
Why?
|
| Placenta | 4 | 2022 | 543 | 0.260 |
Why?
|
| Pregnant Women | 2 | 2024 | 162 | 0.260 |
Why?
|
| Hydroxyurea | 1 | 2006 | 212 | 0.250 |
Why?
|
| Paraproteins | 1 | 2005 | 42 | 0.250 |
Why?
|
| Lymphocyte Activation | 4 | 2011 | 1698 | 0.250 |
Why?
|
| In Situ Hybridization | 5 | 2014 | 1060 | 0.250 |
Why?
|
| Iodide Peroxidase | 1 | 2024 | 27 | 0.240 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2024 | 26 | 0.240 |
Why?
|
| Prognosis | 17 | 2021 | 22229 | 0.240 |
Why?
|
| Mice | 12 | 2024 | 35282 | 0.240 |
Why?
|
| Menopause, Premature | 1 | 2024 | 16 | 0.240 |
Why?
|
| Eclampsia | 1 | 2024 | 28 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 2340 | 0.230 |
Why?
|
| Maternal Age | 1 | 2024 | 155 | 0.230 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2013 | 57 | 0.220 |
Why?
|
| Abortion, Threatened | 1 | 2022 | 2 | 0.220 |
Why?
|
| Glucose Tolerance Test | 1 | 2024 | 225 | 0.220 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2013 | 67 | 0.220 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 117 | 0.220 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 155 | 0.220 |
Why?
|
| Pets | 1 | 2022 | 21 | 0.220 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 4527 | 0.220 |
Why?
|
| Thrombocytopenia | 2 | 2022 | 872 | 0.220 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2001 | 14 | 0.210 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2001 | 19 | 0.210 |
Why?
|
| Choristoma | 1 | 2003 | 84 | 0.210 |
Why?
|
| Point Mutation | 3 | 2012 | 774 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2012 | 4884 | 0.210 |
Why?
|
| Metals, Alkali | 1 | 2022 | 1 | 0.210 |
Why?
|
| Simian Immunodeficiency Virus | 3 | 2007 | 141 | 0.210 |
Why?
|
| DNA, Neoplasm | 6 | 2012 | 1929 | 0.210 |
Why?
|
| Fertility Agents, Female | 1 | 2022 | 14 | 0.210 |
Why?
|
| Inflammasomes | 1 | 2024 | 167 | 0.200 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2005 | 371 | 0.200 |
Why?
|
| Receptor, trkB | 1 | 2022 | 53 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2013 | 64 | 0.200 |
Why?
|
| Physicians | 1 | 2010 | 913 | 0.200 |
Why?
|
| Fertility Preservation | 1 | 2024 | 156 | 0.200 |
Why?
|
| Aluminum | 1 | 2021 | 19 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 588 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2013 | 184 | 0.200 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 590 | 0.200 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 5121 | 0.200 |
Why?
|
| Temperature | 1 | 2023 | 522 | 0.190 |
Why?
|
| DNA-Binding Proteins | 5 | 2016 | 4907 | 0.190 |
Why?
|
| Methylmercury Compounds | 1 | 2021 | 4 | 0.190 |
Why?
|
| Myelodysplastic-Myeloproliferative Diseases | 2 | 2014 | 115 | 0.190 |
Why?
|
| Odds Ratio | 2 | 2023 | 2361 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 1 | 2022 | 282 | 0.190 |
Why?
|
| Cesarean Section | 1 | 2024 | 376 | 0.190 |
Why?
|
| Barium | 1 | 2020 | 26 | 0.190 |
Why?
|
| Rats | 2 | 2023 | 6198 | 0.190 |
Why?
|
| Vulvar Neoplasms | 1 | 2003 | 235 | 0.190 |
Why?
|
| Hospitals, Maternity | 1 | 2020 | 9 | 0.190 |
Why?
|
| Beijing | 1 | 2020 | 13 | 0.190 |
Why?
|
| Dyslipidemias | 1 | 2024 | 242 | 0.190 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1183 | 0.180 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2020 | 100 | 0.180 |
Why?
|
| Central Nervous System Infections | 1 | 2020 | 20 | 0.180 |
Why?
|
| Epithelial Cells | 4 | 2012 | 1848 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2023 | 306 | 0.180 |
Why?
|
| Fatal Outcome | 4 | 2013 | 831 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2024 | 589 | 0.180 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 243 | 0.180 |
Why?
|
| Metals, Rare Earth | 1 | 2020 | 1 | 0.180 |
Why?
|
| Listeria monocytogenes | 1 | 2020 | 53 | 0.180 |
Why?
|
| Cerium | 1 | 2020 | 3 | 0.180 |
Why?
|
| Receptor, Notch1 | 1 | 2022 | 221 | 0.180 |
Why?
|
| Vero Cells | 1 | 2020 | 146 | 0.180 |
Why?
|
| Collagen | 1 | 2023 | 747 | 0.180 |
Why?
|
| Immunization | 3 | 2020 | 402 | 0.180 |
Why?
|
| Germinal Center | 2 | 2011 | 168 | 0.180 |
Why?
|
| Perinatal Death | 1 | 2020 | 31 | 0.180 |
Why?
|
| Folic Acid | 1 | 2023 | 372 | 0.180 |
Why?
|
| Vaccines, Attenuated | 1 | 2020 | 216 | 0.180 |
Why?
|
| Stillbirth | 1 | 2020 | 87 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2015 | 3595 | 0.170 |
Why?
|
| Vaccines, Inactivated | 1 | 2020 | 183 | 0.170 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 309 | 0.170 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2020 | 71 | 0.170 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2006 | 1329 | 0.170 |
Why?
|
| Anemia, Refractory | 2 | 2011 | 39 | 0.170 |
Why?
|
| Cell Proliferation | 5 | 2013 | 7300 | 0.170 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2003 | 441 | 0.170 |
Why?
|
| DNA Polymerase gamma | 1 | 2019 | 15 | 0.170 |
Why?
|
| Hematologic Neoplasms | 2 | 2011 | 1919 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 111 | 0.170 |
Why?
|
| Mental Health | 1 | 2023 | 428 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 1 | 1999 | 95 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 62 | 0.170 |
Why?
|
| Phenylketonurias | 1 | 2019 | 23 | 0.160 |
Why?
|
| Anemia, Sideroblastic | 2 | 2011 | 58 | 0.160 |
Why?
|
| Neutrophils | 3 | 2013 | 844 | 0.160 |
Why?
|
| Monocytes | 2 | 2013 | 785 | 0.160 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 175 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2005 | 769 | 0.160 |
Why?
|
| Survival Rate | 8 | 2022 | 12428 | 0.160 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 1059 | 0.160 |
Why?
|
| Thrombocytosis | 2 | 2011 | 123 | 0.160 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 271 | 0.160 |
Why?
|
| Plasmids | 1 | 2020 | 843 | 0.160 |
Why?
|
| Neoplasm Proteins | 3 | 2022 | 3288 | 0.150 |
Why?
|
| Acute Disease | 4 | 2011 | 2469 | 0.150 |
Why?
|
| Ki-67 Antigen | 2 | 2013 | 681 | 0.150 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2013 | 495 | 0.150 |
Why?
|
| Prevalence | 2 | 2023 | 3397 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 1292 | 0.150 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 523 | 0.150 |
Why?
|
| Glucose | 1 | 2024 | 1267 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 7414 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 3 | 2013 | 5509 | 0.150 |
Why?
|
| Dehydroepiandrosterone | 1 | 2017 | 38 | 0.150 |
Why?
|
| Ovarian Reserve | 1 | 2017 | 14 | 0.150 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2009 | 102 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 325 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 146 | 0.140 |
Why?
|
| Logistic Models | 1 | 2024 | 3519 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 1098 | 0.140 |
Why?
|
| Child | 8 | 2024 | 30093 | 0.140 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2017 | 101 | 0.140 |
Why?
|
| Liver | 2 | 2023 | 2989 | 0.140 |
Why?
|
| Proto-Oncogenes | 2 | 2007 | 202 | 0.140 |
Why?
|
| Trisomy | 2 | 2014 | 229 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 1009 | 0.140 |
Why?
|
| Incidence | 3 | 2021 | 5889 | 0.130 |
Why?
|
| Anticestodal Agents | 1 | 2015 | 4 | 0.130 |
Why?
|
| RNA, Messenger | 4 | 2017 | 6221 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1512 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2021 | 710 | 0.130 |
Why?
|
| Carcinoma, Giant Cell | 1 | 1995 | 9 | 0.130 |
Why?
|
| Lymph Nodes | 5 | 2013 | 3033 | 0.130 |
Why?
|
| Tissue Array Analysis | 3 | 2015 | 764 | 0.130 |
Why?
|
| Time Factors | 6 | 2015 | 13252 | 0.130 |
Why?
|
| Ceruletide | 1 | 2015 | 27 | 0.130 |
Why?
|
| Infertility, Female | 1 | 2017 | 217 | 0.130 |
Why?
|
| Therapeutic Irrigation | 1 | 2015 | 90 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 7154 | 0.130 |
Why?
|
| Retrospective Studies | 9 | 2024 | 39442 | 0.130 |
Why?
|
| Cytoprotection | 1 | 2015 | 66 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2015 | 2847 | 0.130 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2015 | 95 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2013 | 168 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 1018 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2016 | 6265 | 0.120 |
Why?
|
| Tomography, Spiral Computed | 1 | 2015 | 133 | 0.120 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2014 | 4 | 0.120 |
Why?
|
| Radiography, Abdominal | 1 | 2015 | 121 | 0.120 |
Why?
|
| Metronidazole | 1 | 2015 | 154 | 0.120 |
Why?
|
| Biomarkers | 2 | 2024 | 5172 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2016 | 127 | 0.120 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2014 | 31 | 0.120 |
Why?
|
| Gastric Mucosa | 1 | 1998 | 622 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 87 | 0.120 |
Why?
|
| Sepsis | 1 | 2020 | 667 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2014 | 16733 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 9064 | 0.120 |
Why?
|
| Infertility, Male | 1 | 2017 | 306 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2013 | 268 | 0.120 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2015 | 121 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2024 | 5794 | 0.120 |
Why?
|
| SOXC Transcription Factors | 1 | 2014 | 58 | 0.120 |
Why?
|
| Follow-Up Studies | 6 | 2013 | 15182 | 0.120 |
Why?
|
| Vaccination | 1 | 2020 | 1175 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 276 | 0.120 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2014 | 60 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 3 | 1998 | 41 | 0.110 |
Why?
|
| Receptors, Erythropoietin | 1 | 2013 | 70 | 0.110 |
Why?
|
| Pertussis Toxin | 3 | 1998 | 59 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 334 | 0.110 |
Why?
|
| Pedigree | 1 | 2017 | 1930 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2012 | 5292 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 146 | 0.110 |
Why?
|
| Healthy Volunteers | 1 | 2013 | 190 | 0.110 |
Why?
|
| Leukemia, Large Granular Lymphocytic | 1 | 2013 | 64 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2021 | 2111 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 3955 | 0.110 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2012 | 46 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 529 | 0.110 |
Why?
|
| Genes, abl | 2 | 2012 | 115 | 0.110 |
Why?
|
| Splenic Neoplasms | 1 | 2013 | 123 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 2014 | 207 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 430 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1533 | 0.100 |
Why?
|
| Neoplasms | 3 | 2013 | 15698 | 0.100 |
Why?
|
| Kidney | 1 | 2021 | 2183 | 0.100 |
Why?
|
| Texas | 5 | 2016 | 6455 | 0.100 |
Why?
|
| Polycythemia | 1 | 2012 | 54 | 0.100 |
Why?
|
| Electrophoresis, Capillary | 1 | 2011 | 33 | 0.100 |
Why?
|
| Bone Marrow Cells | 3 | 2011 | 928 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2020 | 1673 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 273 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2015 | 5362 | 0.100 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 893 | 0.100 |
Why?
|
| Cell Line | 2 | 2015 | 5127 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2007 | 688 | 0.100 |
Why?
|
| Cytokines | 1 | 2020 | 2867 | 0.100 |
Why?
|
| Janus Kinase 2 | 3 | 2014 | 686 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 403 | 0.090 |
Why?
|
| RNA, Viral | 2 | 2013 | 690 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2015 | 658 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 4845 | 0.090 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 14501 | 0.090 |
Why?
|
| Phenotype | 6 | 2021 | 6395 | 0.090 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 13879 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 1006 | 0.090 |
Why?
|
| Food Parasitology | 1 | 2010 | 5 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2012 | 5817 | 0.090 |
Why?
|
| Snails | 1 | 2010 | 5 | 0.090 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 238 | 0.090 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2010 | 87 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2013 | 582 | 0.090 |
Why?
|
| Fresh Water | 1 | 2010 | 18 | 0.090 |
Why?
|
| Neprilysin | 1 | 2010 | 65 | 0.090 |
Why?
|
| Ovarian Neoplasms | 2 | 2021 | 4730 | 0.090 |
Why?
|
| Medical Audit | 1 | 2011 | 190 | 0.090 |
Why?
|
| Paresthesia | 1 | 2010 | 33 | 0.090 |
Why?
|
| Shellfish | 1 | 2010 | 24 | 0.090 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 87 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2015 | 1057 | 0.090 |
Why?
|
| Neck Pain | 1 | 2010 | 40 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1995 | 1007 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 75 | 0.090 |
Why?
|
| Disease Progression | 4 | 2014 | 6889 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 3148 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2015 | 4885 | 0.090 |
Why?
|
| Patient Admission | 1 | 2011 | 232 | 0.090 |
Why?
|
| Radiography | 2 | 2014 | 1942 | 0.090 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 2 | 2007 | 53 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1995 | 1589 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2014 | 1237 | 0.090 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 1395 | 0.080 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2014 | 570 | 0.080 |
Why?
|
| Headache | 1 | 2010 | 165 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 1506 | 0.080 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 165 | 0.080 |
Why?
|
| Imatinib Mesylate | 2 | 2010 | 1687 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2003 | 592 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 649 | 0.080 |
Why?
|
| Treatment Outcome | 7 | 2021 | 34163 | 0.080 |
Why?
|
| Lactation | 1 | 2009 | 219 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 531 | 0.080 |
Why?
|
| Philadelphia Chromosome | 1 | 2012 | 822 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2022 | 10092 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 4278 | 0.070 |
Why?
|
| Benzamides | 2 | 2010 | 1873 | 0.070 |
Why?
|
| Viral Vaccines | 2 | 2001 | 316 | 0.070 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 5030 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2010 | 449 | 0.070 |
Why?
|
| Breast Implants | 1 | 2012 | 407 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2084 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 5704 | 0.070 |
Why?
|
| VDJ Exons | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cyclin D | 1 | 2006 | 37 | 0.070 |
Why?
|
| ROC Curve | 1 | 2010 | 1224 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2010 | 1569 | 0.070 |
Why?
|
| Heterozygote | 2 | 2021 | 1043 | 0.070 |
Why?
|
| Lymphocytosis | 2 | 1997 | 58 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 6123 | 0.070 |
Why?
|
| Genes, myc | 1 | 2008 | 359 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 153 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2009 | 1181 | 0.070 |
Why?
|
| CD4 Antigens | 2 | 2013 | 173 | 0.070 |
Why?
|
| Mammary Glands, Animal | 1 | 2009 | 546 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2009 | 880 | 0.070 |
Why?
|
| Critical Illness | 1 | 2011 | 745 | 0.070 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2005 | 9 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2016 | 3619 | 0.060 |
Why?
|
| Cytogenetic Analysis | 3 | 2013 | 572 | 0.060 |
Why?
|
| Lymphoma | 1 | 2014 | 1495 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1457 | 0.060 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2005 | 40 | 0.060 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 183 | 0.060 |
Why?
|
| Cyclins | 1 | 2006 | 466 | 0.060 |
Why?
|
| Mammaplasty | 1 | 2012 | 791 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1995 | 1890 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1081 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2011 | 1405 | 0.060 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2006 | 215 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2010 | 2506 | 0.060 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 521 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2005 | 254 | 0.060 |
Why?
|
| Piperazines | 2 | 2010 | 2130 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 9002 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 16050 | 0.060 |
Why?
|
| Virus Replication | 2 | 1998 | 726 | 0.060 |
Why?
|
| Length of Stay | 1 | 2011 | 2025 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 2520 | 0.060 |
Why?
|
| Lassa virus | 2 | 2001 | 23 | 0.060 |
Why?
|
| Immunity, Mucosal | 2 | 2001 | 113 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 1558 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2024 | 149 | 0.060 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2003 | 5 | 0.050 |
Why?
|
| DNA Primers | 2 | 2011 | 1421 | 0.050 |
Why?
|
| Lung | 2 | 2014 | 3240 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2024 | 169 | 0.050 |
Why?
|
| Abnormal Karyotype | 2 | 2013 | 100 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2024 | 182 | 0.050 |
Why?
|
| Silver | 1 | 2022 | 35 | 0.050 |
Why?
|
| Cats | 1 | 2022 | 166 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 1079 | 0.050 |
Why?
|
| Titanium | 1 | 2022 | 66 | 0.050 |
Why?
|
| Infant | 4 | 2022 | 13757 | 0.050 |
Why?
|
| Strontium | 1 | 2022 | 7 | 0.050 |
Why?
|
| Ownership | 1 | 2022 | 41 | 0.050 |
Why?
|
| Tretinoin | 1 | 2005 | 637 | 0.050 |
Why?
|
| Alkalies | 1 | 2022 | 33 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 11816 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 5239 | 0.050 |
Why?
|
| Transfection | 2 | 2015 | 2988 | 0.050 |
Why?
|
| Hemiterpenes | 1 | 2001 | 6 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 162 | 0.050 |
Why?
|
| Macaca mulatta | 3 | 1999 | 768 | 0.050 |
Why?
|
| Copper | 1 | 2022 | 168 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2006 | 1409 | 0.050 |
Why?
|
| HIV | 1 | 2003 | 232 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 2001 | 104 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2022 | 246 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2009 | 1698 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 675 | 0.050 |
Why?
|
| Triglycerides | 1 | 2024 | 621 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 331 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 7732 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2001 | 70 | 0.050 |
Why?
|
| Manganese | 1 | 2021 | 72 | 0.050 |
Why?
|
| Dogs | 1 | 2022 | 1174 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 175 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2022 | 266 | 0.050 |
Why?
|
| Capsid | 1 | 2001 | 104 | 0.050 |
Why?
|
| Pyrimidines | 2 | 2010 | 3603 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 354 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 52 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 4460 | 0.050 |
Why?
|
| Viral Core Proteins | 1 | 2000 | 24 | 0.050 |
Why?
|
| Salmonella | 1 | 2000 | 35 | 0.040 |
Why?
|
| Nucleoproteins | 1 | 2000 | 37 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2001 | 182 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2017 | 2480 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 590 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 14850 | 0.040 |
Why?
|
| Neoplasm Grading | 2 | 2016 | 1807 | 0.040 |
Why?
|
| Cordocentesis | 1 | 2019 | 5 | 0.040 |
Why?
|
| Lymphocyte Subsets | 2 | 1997 | 137 | 0.040 |
Why?
|
| Gene Products, env | 1 | 1999 | 38 | 0.040 |
Why?
|
| Amniocentesis | 1 | 2019 | 73 | 0.040 |
Why?
|
| Fetal Weight | 1 | 2019 | 44 | 0.040 |
Why?
|
| Fertility | 1 | 2022 | 341 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 4442 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 1999 | 1059 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 248 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1999 | 707 | 0.040 |
Why?
|
| Health Status | 1 | 2022 | 616 | 0.040 |
Why?
|
| K562 Cells | 1 | 1999 | 340 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2000 | 361 | 0.040 |
Why?
|
| Chemotaxis | 1 | 1998 | 144 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2023 | 585 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 1999 | 283 | 0.040 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2021 | 325 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 1380 | 0.040 |
Why?
|
| RNA Interference | 2 | 2014 | 1411 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 1998 | 578 | 0.040 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2020 | 225 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 1075 | 0.040 |
Why?
|
| Receptors, FSH | 1 | 2017 | 21 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 6192 | 0.040 |
Why?
|
| Haplotypes | 1 | 2020 | 883 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 350 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 186 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1998 | 702 | 0.040 |
Why?
|
| Ovulation Induction | 1 | 2017 | 64 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 2221 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 2017 | 148 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 7901 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2000 | 5663 | 0.030 |
Why?
|
| Tennessee | 1 | 2016 | 37 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 1653 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1998 | 587 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2017 | 204 | 0.030 |
Why?
|
| Risk | 1 | 2020 | 1998 | 0.030 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 2015 | 37 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 595 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 913 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 3143 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 849 | 0.030 |
Why?
|
| Gene Expression | 2 | 2013 | 3594 | 0.030 |
Why?
|
| Lymphocyte Count | 3 | 2003 | 489 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 1578 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 7959 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1625 | 0.030 |
Why?
|
| Chloroquine | 1 | 2012 | 56 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 131 | 0.030 |
Why?
|
| CD8 Antigens | 1 | 2013 | 173 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2013 | 16258 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 1556 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 2278 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2012 | 81 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2015 | 745 | 0.030 |
Why?
|
| Complementarity Determining Regions | 2 | 2003 | 44 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2012 | 156 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2012 | 261 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 1532 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 2012 | 263 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 158 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 1082 | 0.020 |
Why?
|
| Autoantigens | 1 | 2012 | 238 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2012 | 172 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 219 | 0.020 |
Why?
|
| Base Sequence | 2 | 2012 | 4929 | 0.020 |
Why?
|
| Diploidy | 1 | 2011 | 112 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2011 | 114 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 558 | 0.020 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2010 | 10 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 20 | 0.020 |
Why?
|
| Genotype | 1 | 2019 | 4167 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 174 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 518 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 342 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2010 | 158 | 0.020 |
Why?
|
| Device Removal | 1 | 2012 | 355 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 200 | 0.020 |
Why?
|
| HIV Infections | 1 | 2003 | 2217 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2009 | 73 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2011 | 292 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2010 | 120 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1082 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 804 | 0.020 |
Why?
|
| Quality of Life | 1 | 2024 | 4719 | 0.020 |
Why?
|
| Breast Implantation | 1 | 2012 | 242 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 1607 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2009 | 698 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 512 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 5028 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2009 | 259 | 0.020 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2008 | 9 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 2018 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 3483 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 909 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 10254 | 0.020 |
Why?
|
| Mice, Nude | 1 | 1995 | 4343 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 652 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 4639 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2007 | 87 | 0.020 |
Why?
|
| Macaca | 1 | 2007 | 100 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 4229 | 0.020 |
Why?
|
| World Health Organization | 1 | 2007 | 320 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 5113 | 0.020 |
Why?
|
| Anemia | 1 | 2012 | 726 | 0.020 |
Why?
|
| Viremia | 1 | 2007 | 183 | 0.020 |
Why?
|
| Mastectomy | 1 | 2012 | 1557 | 0.020 |
Why?
|
| Breast | 1 | 2012 | 1362 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2005 | 129 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 2215 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2001 | 1018 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2001 | 1712 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 3621 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 1642 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 1503 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2007 | 443 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 1497 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1768 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 3480 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3105 | 0.010 |
Why?
|
| RNA, Long Noncoding | 1 | 2007 | 612 | 0.010 |
Why?
|
| Lassa Fever | 1 | 2001 | 9 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 5490 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2001 | 85 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 1226 | 0.010 |
Why?
|
| Nucleocapsid Proteins | 1 | 2000 | 12 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2001 | 271 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2008 | 2095 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 880 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 4873 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 9320 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2010 | 1844 | 0.010 |
Why?
|
| Proteins | 1 | 2007 | 1985 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1997 | 1657 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 595 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 2554 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 296 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1996 | 705 | 0.010 |
Why?
|
| Sarcoma | 1 | 2006 | 1830 | 0.010 |
Why?
|
| Viral Load | 1 | 1997 | 487 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1997 | 674 | 0.010 |
Why?
|